Security key
002824100
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 1,316,417,932
- Total 13F value
- $136,784,452,486
- Share change
- +20,994,797
- Put/Call ratio
- 83%
- SEC-reported price per share
- $103.91
- Number of holders
- 2,843
- Value change
- +$2,136,359,246
- Number of buys
- 1,231
- Number of sells
- 1,338
- Shares outstanding
- 1,742,357,013
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
2,843
Top holders
10
ABT full security history
Ownership snapshot
Full 13F holder table
ABBOTT LABORATORIES SEC filings
ABBOTT LABORATORIES company facts
Broader feeds
Ownership snapshot
Top reported holders of ABT - ABBOTT LABORATORIES - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F
Highest disclosed value: $18,788,216,342
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $18.79B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$18.79B
BlackRock Finance, Inc.
$15.13B
Capital Research Global Investors
$9.55B
STATE STREET CORP
$8.49B
Capital International Investors
$7.98B
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$18,788,216,342
165,301,921 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$15,125,444,103
133,076,228 shares
|
— | 31 Mar 2024 |
| Capital Research Global Investors |
13F
Company
|
—
denominator unverified
|
$9,545,704,545
83,984,731 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$8,494,793,822
74,738,640 shares
|
— | 31 Mar 2024 |
| Capital International Investors |
13F
Company
|
—
denominator unverified
|
$7,976,381,992
70,177,564 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$4,093,122,195
36,011,982 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2,843
Shares
1,316,417,932
Rows available
2,843
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
2,884
Q2 2024 holders
2,843
Holder diff
-41
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|